MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock via...
$137,090K
Proceeds from issuance of
common stock through...
$1,675K
Proceeds from maturities
and sales of...
$83,800K
Net cash provided by
financing activities
$138,782K
Net cash provided by
investing activities
$32,901K
Canceled cashflow
$50,899K
Net increase
(decrease) in cash, cash...
$120,571K
Canceled cashflow
$51,112K
Stock compensation
expense
$10,537K
Prepaid expenses and
other current assets
-$7,364K
Accounts payable and
accrued expenses
$3,666K
Operating lease assets and
liabilities, net
-$506K
Depreciation expense
$504K
Other liabilities
$384K
Purchases of investments
$50,899K
Net cash used in
operating activities
-$51,112K
Canceled cashflow
$22,961K
Net loss
-$73,291K
Net amortization of
premiums and discounts on...
$782K
Back
Back
Cash Flow
Relay Therapeutics, Inc. (RLAY)
Relay Therapeutics, Inc. (RLAY)
source: myfinsight.com